03:35 PM EDT, 08/04/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lift our target to $765 from $577, 54.8x our 2026 EPS view, above IDEXX's ( IDXX ) five-year historical forward P/E average of 52.5x, justified by its strengthening outlook as we see the company benefitting from elevated pet ownership and aging pet population trends. We raise our 2025 EPS estimate to $12.66 from $12.23 and our 2026 EPS to $13.97 from $13.69. IDEXX ( IDXX ) posted a strong performance in Q2 2025, beating expectations with Q2 revenue up a robust 11% Y/Y. CAG Diagnostics recurring revenue, a key performance indicator, grew by 9% Y/Y, demonstrating the continued strength of IDEXX's ( IDXX ) core business. In our view, IDXX's strategic focus on innovation and rapid expansion of its premium instrument installed base is yielding results, as seen by record quarterly placements in Q2 (nearly 2,400 IDEXX ( IDXX ) inVue Dx). This success, coupled with the company's strong execution, positions IDEXX ( IDXX ) well for sustained long-term growth, in our view.